HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French Fragrances

This article was originally published in The Rose Sheet

Executive Summary

Net sales rose 43.7% to $309.6 mil. and gross profit was up 28.3% to $88.5 mil. for the year ended Jan. 31. Net income dipped slightly (2.7%) to $12 mil. Net sales in the fourth quarter grew 60.2% to $88.7 mil. from $55.4 mil. in the year-ago period. Gross profit climbed 32.2% to $23.2 mil. and net income was up 16.3% to $3.2 mil. French Fragrances noted gross margins are "expected to improve" in FY 2000 due to improved sales of owned and licensed brands related to the company's January acquisition of Paul Sebastian, which includes the Nautica brand ("The Rose Sheet" Jan. 25, p. 10). Sebastian remains "a promising acquisition going forward," the firm said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel